Prognoix (Singapore + the Netherlands) is a digital medicine company developing evidence-based digital therapeutics. Its flagship product, Melonga, a clinically validated digital therapeutic for premature ejaculation, delivers structured behavioural therapy through the Melonga app to improve sexual control and confidence. Melonga combines clinical science, digital medicine and scalable technology to provide accessible, drug-free treatment for men worldwide.